TERT and neoplasm: The novel ddPCR assay protocol was developed to detect TERT breakpoints which correlated well with results obtained with the independent methodologies, hybrid capture–based panel sequencing, and TERT break-apart FISH while only requiring input DNA amounts in the low nanogram range to reliably detect and quantify tumor-specific breakpoint copy numbers.